Your browser is no longer supported. Please, upgrade your browser.
Settings
RMD ResMed Inc. daily Stock Chart
RMD [NYSE]
ResMed Inc.
Index- P/E28.83 EPS (ttm)2.36 Insider Own0.80% Shs Outstand140.60M Perf Week-2.65%
Market Cap9.56B Forward P/E21.88 EPS next Y3.11 Insider Trans-15.07% Shs Float140.14M Perf Month-6.19%
Income334.30M PEG2.74 EPS next Q0.71 Inst Own64.50% Short Float7.85% Perf Quarter0.26%
Sales1.97B P/S4.86 EPS this Y0.70% Inst Trans0.15% Short Ratio15.60 Perf Half Y13.48%
Book/sh12.10 P/B5.62 EPS next Y10.29% ROA10.80% Target Price64.46 Perf Year22.81%
Cash/sh5.61 P/C12.13 EPS next 5Y10.53% ROE19.50% 52W Range54.31 - 73.46 Perf YTD10.10%
Dividend1.32 P/FCF117.44 EPS past 5Y11.50% ROI11.90% 52W High-7.45% Beta0.90
Dividend %1.94% Quick Ratio1.90 Sales past 5Y8.10% Gross Margin57.90% 52W Low25.19% ATR1.43
Employees5250 Current Ratio2.20 Sales Q/Q16.70% Oper. Margin21.00% RSI (14)38.94 Volatility2.26% 1.61%
OptionableYes Debt/Eq0.68 EPS Q/Q-20.60% Profit Margin17.00% Rel Volume4.28 Prev Close72.85
ShortableYes LT Debt/Eq0.51 EarningsApr 27 AMC Payout53.00% Avg Volume705.46K Price67.99
Recom2.80 SMA20-2.90% SMA50-4.29% SMA2003.56% Volume3,020,934 Change-6.67%
Apr-28-17Downgrade Citigroup Buy → Neutral
Jan-24-17Upgrade JP Morgan Neutral → Overweight
Jan-24-17Reiterated Canaccord Genuity Hold $55 → $59
Oct-04-16Initiated JP Morgan Neutral $64
Aug-23-16Downgrade Jefferies Hold → Underperform
Jun-27-16Downgrade Needham Hold → Underperform
Apr-28-16Upgrade Macquarie Underperform → Neutral
Apr-27-16Downgrade Piper Jaffray Overweight → Neutral
Apr-07-16Resumed Barclays Underweight $55
Jan-22-16Upgrade Credit Suisse Neutral → Outperform
Jan-19-16Downgrade Barclays Equal Weight → Underweight $61 → $52
Dec-17-15Downgrade Needham Buy → Hold
Jul-13-15Downgrade Macquarie Neutral → Underperform
Jun-25-15Initiated Barclays Equal Weight $61
May-14-15Reiterated Needham Buy $77 → $65
May-13-15Downgrade BofA/Merrill Buy → Neutral
Apr-27-15Downgrade Goldman Buy → Neutral
Apr-24-15Downgrade Macquarie Outperform → Neutral
Jan-27-15Reiterated Northland Capital Under Perform $40 → $44
Jan-23-15Upgrade Needham Hold → Buy
Apr-28-17 05:11PM  ResMed, Inc. Value Analysis (NYSE:RMD) : April 28, 2017 Capital Cube -6.67%
01:52PM  Edited Transcript of RMD earnings conference call or presentation 27-Apr-17 8:30pm GMT Thomson Reuters StreetEvents
10:55AM  ResMed (RMD) Beats Q3 Earnings, Misses Sales Estimates Zacks
Apr-27-17 06:02PM  ResMed tops 3Q profit forecasts Associated Press
04:05PM  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2017 PR Newswire
08:35AM  ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : April 27, 2017 Capital Cube
Apr-26-17 08:19AM  Medical Product Stocks' Earnings on Apr 27: ZBH, RMD & More Zacks
Apr-25-17 09:39AM  ResMed Unveils AirMini - the World's Smallest CPAP PR Newswire
09:19AM  ResMed Unveils AirMini - the World's Smallest CPAP CNW Group
Apr-18-17 09:27AM  ResMed (RMD) Q3 Earnings: Disappointment in the Cards? Zacks
Apr-11-17 04:17PM  ResMed's Study Results for Central Sleep Apnea Hold Promise Zacks
Apr-07-17 05:24PM  ETFs with exposure to ResMed, Inc. : April 7, 2017 Capital Cube
Apr-06-17 09:00AM  New ResMed-sponsored Study Shows Promising Treatment Option for Patients with Untreated Central Sleep Apnea PR Newswire
Apr-05-17 08:24AM  ResMed, Inc. breached its 50 day moving average in a Bearish Manner : RMD-US : April 5, 2017 Capital Cube
Mar-30-17 04:05PM  ResMed to Announce Third Quarter Fiscal Year 2017 Results PR Newswire
Mar-27-17 08:12AM  Align Partners Zfx GmbH to Expand iTero Scanner Business Zacks
08:09AM  VWR Corp Acquires EPL Archives, Improves Customer Service Zacks
Mar-24-17 12:27PM  PetMed Express' New Order Sales Disappoint, Competition Rife Zacks
09:30AM  Zacks Industry Outlook Highlights: Quidel, OraSure Technologies, ResMed, Inogen and Masimo
09:04AM  Walgreen Boots Buyout of Rite Aid Delayed, Other Woes Remain Zacks
Mar-23-17 04:17PM  Medtronic's (MDT) CoreValve Evolut Pro Receives FDA Approval Zacks
08:48AM  Hologic Completes Cynosure Buyout, Boosts Core Business Zacks
Mar-22-17 09:29AM  Align's iTero Hits 1 Billion Mark, Boosts Scanner Business Zacks
09:11AM  Genomic Health's Cancer Test Business Strong, Expenses High
09:00AM  Brightree Expands Sleep Therapy Capabilities with ResMeds AirView Platform Business Wire
Mar-21-17 10:58AM  Integer (ITGR) Amends Term B Loan to Lower Interest Rate
08:34AM  Genomic Health's Breast Recurrence Test Data Encouraging
Mar-20-17 06:05PM  Research on Treating Sleep Apnea with Adaptive Servo-ventilation Published in the Journal of the American College of Cardiology (JACC) PR Newswire
09:40AM  Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve
09:14AM  Abbott Laboratories' MitraClip Outcome Positive for DMR
Mar-17-17 04:05PM  Thermo Fisher Poised on Innovation, Global Growth Amid Woes
09:18AM  CVS Health Launches Reduced Rx for Affordable Medication
Mar-16-17 09:34AM  Align Technology Hits a 52-Week High on Solid Prospects
Feb-25-17 09:34AM  3 Healthcare Stocks to Invest In at Motley Fool
Feb-23-17 04:35AM  ResMed (RMD) Up 3.6% Since Earnings Report: Can It Continue?
Feb-13-17 09:00AM  ResMed Named Global Leader in Remote Patient Monitoring PR Newswire
Jan-30-17 08:15AM  Post Earnings Coverage as ResMed Revenue Increased 17% Accesswire
Jan-28-17 01:04PM  RESMED INC Financials
Jan-25-17 01:30PM  ETFs with exposure to ResMed, Inc. : January 25, 2017
08:43AM  ResMed's Revenue Jumps, but Higher Costs Keep Profits in Check at Motley Fool
06:27AM  Here's Why This Rally Is Sustainable: Cramer's 'Mad Money' Recap (Tuesday 1/24/17)
06:23AM  ResMed: Cramer's Top Takeaways
06:05AM  RESMED INC Files SEC form 10-Q, Quarterly Report
Jan-24-17 07:25PM  Cramer Remix: The best way to play the oil patch at CNBC +9.62%
04:32PM  ResMed stock surges after strong quarterly results at CNBC
04:27PM  Breaking Out: ResMed Stock Launches As Fiscal Q2 Sales, EPS Beat
03:08PM  ResMed Reports Q2 Profit of $76.7M (RMD) at Investopedia
12:48PM  Why ResMed Is in the Green Today at Motley Fool
10:57AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q2, 2017 By the Numbers : January 24, 2017
09:04AM  Morning Movers: Lockheed Martin Tumbles, Johnson & Johnson Slips, AK Steel Soars at Barrons.com
08:12AM  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
07:49AM  ResMed upgraded by JP Morgan
01:09AM  BlueScope, ResMed news boosts share market Other
Jan-23-17 08:43PM  ResMed Q2 profit down but revenue up Other
08:42PM  Edited Transcript of RMD earnings conference call or presentation 23-Jan-17 9:30pm GMT
06:04PM  After hours buzz: YHOO, RMD, MRCY at CNBC
04:14PM  ResMed tops Street 2Q forecasts AP
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017 PR Newswire
07:07AM  Q2 2017 ResMed Inc Earnings Release - 4:00 pm ET
Jan-20-17 05:28PM  ResMed and BMC/3B Medical Settle Global Litigation PR Newswire
08:14AM  Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD Other
Jan-13-17 06:37AM  ResMed (RMD) Q2 Earnings: Disappointment in the Cards? Zacks
Jan-12-17 04:26PM  RESMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation
03:00AM  ResMed's myAir Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea PR Newswire
Jan-11-17 07:27AM  Why a Massive Short Squeeze Could Send These 4 Stocks Into Orbit at TheStreet
Jan-09-17 09:00AM  FDA Clears World's Smallest CPAP, ResMed AirMini PR Newswire
07:30AM  ResMed and Dr. Oz Form SleepScore Labs for Sleep Disorders Zacks
Jan-07-17 09:48PM  CES: These Gadgets Will Literally Put You To Sleep at Investor's Business Daily
Jan-06-17 04:48PM  [$$] Pegasus Teams Up With Dr. Oz, ResMed to Launch SleepScore Labs at The Wall Street Journal
02:30PM  Largest Consumer Sleep Study Just Released at CES 2017 Business Wire
09:00AM  Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep PR Newswire
Jan-05-17 06:52AM  ResMed Achieves Key Milestone in Sleep-Disordered Breathing Zacks
Jan-04-17 09:00AM  ResMed Reaches Historic One Billionth Night of Sleep Monitored PR Newswire
Dec-29-16 08:02AM  ResMed: SDB Business Faces Risks, Reimbursement a Drag Zacks
Dec-23-16 09:21AM  What Do Analysts Recommend for Baxter International?
Dec-20-16 09:00AM  ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer PR Newswire
Dec-19-16 04:05PM  ResMed to Announce Second Quarter Fiscal Year 2017 Results PR Newswire
Dec-04-16 12:59PM  Should You Add ResMed Inc. (RMD) to Your Portfolio? at Insider Monkey
Dec-01-16 04:18PM  ResMed loses in Fisher &Paykel; dispute Other
04:18PM  Fisher & Paykel wins German court case against ResMed Reuters
11:20AM  ETFs with exposure to ResMed, Inc. : December 1, 2016
Nov-30-16 07:12AM  ResMed, Inc. breached its 50 day moving average in a Bullish Manner : RMD-US : November 30, 2016
Nov-18-16 02:33PM  RESMED INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Nov-01-16 09:05AM  ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers PR Newswire
09:00AM  ResMed Introduces AirFit(TM) N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort PR Newswire
09:00AM  ResMed Introduces AirFit N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort PR Newswire
Oct-31-16 02:06PM  ETFs with exposure to ResMed, Inc. : October 31, 2016
Oct-28-16 06:06AM  RESMED INC Files SEC form 10-Q, Quarterly Report
Oct-26-16 02:28PM  ResMed (RMD) Stock Sharply Lower After Q1 Results Miss Estimates at TheStreet -5.58%
10:40AM  ResMed (RMD) Misses Earnings & Revenue Estimates in Q1
09:46AM  ResMed, Inc. :RMD-US: Earnings Analysis: Q1, 2017 By the Numbers : October 26, 2016
01:41AM  ResMed slips on first quarter income drop Other
Oct-25-16 09:18PM  Edited Transcript of RMD earnings conference call or presentation 25-Oct-16 8:30pm GMT
08:25PM  ResMed's profit down despite revenue rise Other
04:11PM  ResMed misses Street 1Q forecasts AP
04:07PM  RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements and
04:05PM  ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2017 PR Newswire
ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBERTS CHRISTOPHER GDirectorApr 24Option Exercise30.4152,7931,605,298198,403Apr 25 07:16 PM
Hollingshead JamesPresident, AmericasApr 17Option Exercise43.635,264229,66844,934Apr 18 02:55 PM
Hollingshead JamesPresident, AmericasApr 17Sale68.377,139488,09337,795Apr 18 02:55 PM
FARRELL PETER CDirectorApr 04Option Exercise27.5820,000551,600321,557Apr 06 01:14 PM
FARRELL PETER CDirectorApr 04Sale70.6720,0001,413,360301,557Apr 06 01:14 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Option Exercise27.586,365175,54784,261Apr 04 05:58 PM
Sandercock BrettChief Financial OfficerApr 03Sale71.651,25089,56364,033Apr 04 07:52 PM
PENDARVIS DAVIDChief Administrative OfficerApr 03Sale71.596,365455,64577,896Apr 04 05:58 PM
FARRELL PETER CDirectorMar 06Option Exercise32.5020,000650,040321,557Mar 08 03:51 PM
FARRELL PETER CDirectorMar 06Sale71.7020,0001,434,000301,557Mar 08 03:51 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Option Exercise27.586,365175,54784,261Mar 06 04:02 PM
PENDARVIS DAVIDChief Administrative OfficerMar 03Sale72.226,365459,68077,896Mar 06 04:02 PM
Sandercock BrettChief Financial OfficerMar 01Sale72.481,25090,60065,283Mar 02 09:57 PM
ROBERTS CHRISTOPHER GDirectorFeb 22Sale72.1015,0001,081,500298,900Feb 24 03:22 PM
ROBERTS CHRISTOPHER GDirectorFeb 20Sale71.9110,000719,100313,900Feb 21 02:11 PM
FARRELL PETER CDirectorFeb 06Option Exercise33.7020,000674,000321,557Feb 07 03:14 PM
FARRELL PETER CDirectorFeb 06Sale68.3220,0001,366,420301,557Feb 07 03:14 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Option Exercise27.586,365175,54784,261Feb 06 03:22 PM
PENDARVIS DAVIDChief Administrative OfficerFeb 03Sale67.166,365427,47377,896Feb 06 03:22 PM
Hollingshead JamesPresident, AmericasJan 17Option Exercise43.635,264229,66846,754Jan 19 05:22 PM
Hollingshead JamesPresident, AmericasJan 17Sale64.447,084456,49339,670Jan 19 05:22 PM
FARRELL PETER CDirectorJan 04Option Exercise33.7020,000674,000321,557Jan 05 05:24 PM
FARRELL PETER CDirectorJan 04Sale62.1420,0001,242,760301,557Jan 05 05:24 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Option Exercise27.586,365175,54784,261Jan 04 04:01 PM
PENDARVIS DAVIDChief Administrative OfficerJan 03Sale61.956,365394,31277,896Jan 04 04:01 PM
FARRELL PETER CDirectorDec 05Option Exercise33.7020,000674,000372,407Dec 06 04:49 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Option Exercise27.586,365175,54784,261Dec 06 04:50 PM
PENDARVIS DAVIDChief Administrative OfficerDec 05Sale60.006,365381,90077,896Dec 06 04:50 PM
FARRELL PETER CDirectorDec 05Sale59.8320,0001,196,540352,407Dec 06 04:49 PM
FARRELL PETER CDirectorNov 04Option Exercise33.7020,000674,000367,978Nov 07 02:16 PM
FARRELL PETER CDirectorNov 04Sale57.2820,0001,145,560347,978Nov 07 02:16 PM
PENDARVIS DAVIDChief Administrative OfficerNov 03Option Exercise33.706,033203,31287,306Nov 07 11:40 AM
PENDARVIS DAVIDChief Administrative OfficerNov 03Sale57.796,033348,64781,273Nov 07 11:40 AM
ROBERTS CHRISTOPHER GDirectorOct 19Option Exercise25.5436,000919,440145,610Oct 24 12:27 PM
Hollingshead JamesPresident, AmericasOct 18Sale64.711,967127,28545,513Oct 19 08:09 PM
Farrell Michael J.Chief Executive OfficerOct 17Option Exercise33.705,975201,358203,781Oct 18 03:49 PM
Hollingshead JamesPresident, AmericasOct 17Option Exercise43.635,264229,66852,744Oct 18 08:13 PM
Hollingshead JamesPresident, AmericasOct 17Sale64.435,264339,16047,480Oct 18 08:13 PM
Farrell Michael J.Chief Executive OfficerOct 17Sale64.255,975383,870197,806Oct 18 03:49 PM
FARRELL PETER CDirectorOct 04Option Exercise27.1420,000542,746367,978Oct 06 03:59 PM
FARRELL PETER CDirectorOct 04Sale64.7020,0001,293,960347,978Oct 06 03:59 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Option Exercise33.706,000202,20087,061Oct 04 05:30 PM
PENDARVIS DAVIDChief Administrative OfficerOct 03Sale63.956,000383,71881,061Oct 04 05:30 PM
Farrell Michael J.Chief Executive OfficerSep 15Option Exercise33.705,975201,358203,781Sep 16 09:15 PM
Farrell Michael J.Chief Executive OfficerSep 15Sale64.845,975387,419197,806Sep 16 09:15 PM
PENDARVIS DAVIDChief Administrative OfficerSep 06Option Exercise33.706,000202,20087,061Sep 08 12:43 PM
FARRELL PETER CDirectorSep 06Option Exercise25.5420,000510,800367,978Sep 08 12:44 PM
FARRELL PETER CDirectorSep 06Sale67.2920,0001,345,760347,978Sep 08 12:44 PM
PENDARVIS DAVIDChief Administrative OfficerSep 06Sale67.186,000403,05081,061Sep 08 12:43 PM
PACE GARY WDirectorAug 19Option Exercise25.5436,000919,440129,158Aug 22 06:18 PM
PACE GARY WDirectorAug 19Sale69.9336,0002,517,33693,158Aug 22 06:18 PM
TAYLOR RONALD RDirectorAug 17Buy69.132,487171,92619,216Aug 17 09:08 PM
TAYLOR RONALD RDirectorAug 16Sale69.2523,1021,599,81416,729Aug 17 09:08 PM
Farrell Michael J.Chief Executive OfficerAug 15Option Exercise33.705,975201,358154,814Aug 15 07:55 PM
Farrell Michael J.Chief Executive OfficerAug 15Sale70.415,975420,700148,839Aug 15 07:55 PM
Sandercock BrettChief Financial OfficerAug 11Sale70.5035,0002,467,50051,084Aug 11 07:33 PM
SULPIZIO RICHARDDirectorAug 10Option Exercise25.5436,000919,440101,887Aug 11 02:31 PM
SULPIZIO RICHARDDirectorAug 10Sale70.1536,0002,525,29265,887Aug 11 02:31 PM
WAREHAM JOHN PDirectorAug 08Option Exercise33.7024,390821,94337,390Aug 10 12:14 PM
WAREHAM JOHN PDirectorAug 08Sale70.3224,3901,714,98313,000Aug 10 12:14 PM
FARRELL PETER CDirectorAug 04Option Exercise25.5420,000510,800367,978Aug 05 08:31 PM
FARRELL PETER CDirectorAug 04Sale69.1620,0001,383,260347,978Aug 05 08:31 PM
PENDARVIS DAVIDChief Administrative OfficerAug 03Option Exercise33.706,000202,20080,512Aug 05 11:42 AM
PENDARVIS DAVIDChief Administrative OfficerAug 03Sale68.866,000413,13674,512Aug 05 11:42 AM
Farrell Michael J.Chief Executive OfficerJul 15Option Exercise33.705,975201,358154,814Jul 19 04:23 PM
Farrell Michael J.Chief Executive OfficerJul 15Sale65.035,975388,554148,839Jul 19 04:23 PM
Hollingshead JamesPresident, AmericasJul 14Sale65.022,753178,99440,669Jul 14 09:24 PM
FARRELL PETER CDirectorJul 07Sale63.6220,0001,272,400347,978Jul 07 06:17 PM
PENDARVIS DAVIDChief Administrative OfficerJul 05Option Exercise33.706,000202,20080,512Jul 06 04:47 PM
FARRELL PETER CDirectorJul 05Option Exercise25.5420,000510,800367,978Jul 07 06:17 PM
PENDARVIS DAVIDChief Administrative OfficerJul 05Sale63.626,000381,72074,512Jul 06 04:47 PM
Farrell Michael J.Chief Executive OfficerJun 15Option Exercise33.705,975201,358154,814Jun 16 02:37 PM
Farrell Michael J.Chief Executive OfficerJun 15Sale59.635,975356,289148,839Jun 16 02:37 PM
Hollingshead JamesPresident, AmericasJun 15Sale59.404,458264,82743,422Jun 16 12:54 PM
FARRELL PETER CDirectorJun 06Option Exercise25.5420,000510,800367,978Jun 08 01:52 PM
FARRELL PETER CDirectorJun 06Sale59.8220,0001,196,400347,978Jun 08 01:52 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Option Exercise33.706,000202,20080,512Jun 06 05:22 PM
PENDARVIS DAVIDChief Administrative OfficerJun 03Sale59.416,000356,46074,512Jun 06 05:22 PM
Farrell Michael J.Chief Executive OfficerMay 16Option Exercise33.705,975201,358154,723May 17 06:10 PM
Farrell Michael J.Chief Executive OfficerMay 16Sale57.645,975344,369148,748May 17 06:10 PM
FARRELL PETER CDirectorMay 04Option Exercise25.5420,000510,800367,978May 06 12:25 PM
FARRELL PETER CDirectorMay 04Sale55.9020,0001,118,000347,978May 06 12:25 PM
PENDARVIS DAVIDChief Administrative OfficerMay 03Option Exercise33.706,000202,20080,287May 05 09:08 AM
PENDARVIS DAVIDChief Administrative OfficerMay 03Sale56.026,000336,12074,287May 05 09:08 AM